米国の止血バルブの市場規模、シェア、動向分析レポート：タイプ別、用途別、最終用途別、セグメント別予測、2025年～2033年

米国の止血バルブ市場規模・動向：

米国の止血バルブ市場規模は、2024年に6,447万米ドルと推定され、2025年から2033年にかけてCAGR 5.4％で成長すると予測されています。

同市場は、心血管疾患の罹患率の上昇、有利な規制支援、高齢化、継続的な技術進歩など、いくつかの重要な要因によって大きな成長を遂げています。特筆すべき促進要因は、低侵襲手術への嗜好が高まっていることです。低侵襲手術は、従来の開腹手術に比べて痛みが少なく、入院期間が短く、回復が早く、合併症のリスクが低いなどの利点があります。

このシフトは、これらの手技をサポートする医療機器に対する需要を煽っています。止血バルブは、低侵襲のカテーテルを用いた手技において、制御された血流を確保し、手技中の漏れを防ぐという重要な役割を果たしています。

大気汚染は、心血管系疾患の増加の主な原因であるとの認識が高まっています。World Heart Report 2024は、大気汚染がすべての主要な心血管疾患（CVD）を悪化させることを強調しています。2019年には、周囲の大気汚染に関連する420万人の死亡のうち70％近くが心血管問題、特に虚血性心疾患（190万人の死亡）と脳卒中（90万人の死亡）によるものでした。その結果、血管造影術や血管形成術などの診断・治療手技の必要性が高まっており、止血バルブはカテーテルを使ったインターベンションの際に血流を調整することで、患者の安全性を維持する上で重要な役割を果たしています。

医療機器の技術的進歩は市場成長の極めて重要な原動力です。止血バルブの性能と信頼性を向上させる上で、継続的な技術進歩が重要な役割を果たしています。メーカー各社は、バルブのデザイン、素材品質、多様なカテーテルサイズやインターベンションツールとの適合性を高めるための技術革新を継続的に行っています。これらの改良は、血液漏れのリスクを低減し、臨床医にとっての使いやすさを向上させ、低侵襲手技中の患者の安全性を高めるのに役立っています。例えば、メリットメディカルシステムズ社は、人間工学に基づいた機能、優れたシール機構、堅牢な止血制御を備えたMerit AccessPLUSやHonor止血バルブなどの先進的な止血バルブを提供しています。これらの技術革新は、カテーテルを用いたインターベンションにおける手技効率の最適化と合併症の減少に重点を置く業界の姿勢を反映しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 米国の止血バルブ市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 米国の止血バルブ市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析

第4章 米国の止血バルブ市場：タイプ別推定・動向分析

• 米国の止血バルブ市場：タイプダッシュボード
• 米国の止血バルブ市場：タイプ変動分析
• 米国の止血バルブ市場（タイプ別、売上高別）
• 止血バルブYコネクタ
• ダブルYコネクタ止血バルブ
• 片手止血バルブ
• その他

第5章 米国の止血バルブ市場：用途の推定・動向分析

• 米国の止血バルブ市場：用途ダッシュボード
• 米国の止血バルブ市場：用途変動分析
• 米国の止血バルブ市場（用途別、売上高別）
• 血管造影検査
• 血管形成術
  • 2021年から2033年までの市場推計・予測

第6章 米国の止血バルブ市場：最終用途の推定・動向分析

• 米国の止血バルブ市場：最終用途ダッシュボード
• 米国の止血バルブ市場：最終用途変動分析
• 米国の止血バルブ市場：用途別、売上高別
• 病院
• 外来手術センター
• その他

第7章 競合情勢

• 主要メーカーによる最近の動向と影響分析
• 企業/競合の分類
• ベンダー情勢
  • Key company market share analysis, 2024
• 企業プロファイル
  • Boston Scientific Corporation
  • Teleflex Incorporated
  • Merit Medical Systems
  • B. Braun
  • Terumo Corporation
  • Abbott
  • Argon Medical Devices
  • Freudenberg Medical
  • DeRoyal Industries, Inc.
  • Antmed Corporation

List of Tables

• Table 1 List of Abbreviations
• Table 2 List of secondary sources
• Table 3 U.S. Hemostasis Valve market, by type, 2018 - 2030 (USD Million)
• Table 4 U.S. Hemostasis Valve market, by application, 2018 - 2030 (USD Million)
• Table 5 U.S. Hemostasis Valve market, by end use, 2018 - 2030 (USD Million)
• Table 6 Participant's overview
• Table 7 Financial performance
• Table 8 Key companies undergoing expansions
• Table 9 Key companies undergoing acquisitions
• Table 10 Key companies undergoing collaborations
• Table 11 Key companies launching new services
• Table 12 Key companies undergoing partnerships
• Table 13 Key companies undertaking other strategies

List of Figures

• Fig. 1 Market research process
• Fig. 2 Information procurement
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Market formulation & validation
• Fig. 6 U.S. Hemostasis Valve market segmentation
• Fig. 7 Market snapshot, 2024
• Fig. 8 Market trends & outlook
• Fig. 9 Market driver relevance analysis (current & future impact)
• Fig. 10 Market restraint relevance analysis (current & future impact)
• Fig. 11 Swot analysis, by factor (political & legal, economic and technological)
• Fig. 12 Porter's five forces analysis
• Fig. 13 U.S. Hemostasis Valve market: Type Outlook Key Takeaways
• Fig. 14 U.S. Hemostasis Valve market: Type Movement Analysis
• Fig. 15 Hemostasis Valve Y-Connectors market, 2018 - 2030 (USD Million)
• Fig. 16 Double Y-Connector Hemostasis Valves market, 2018 - 2030 (USD Million)
• Fig. 17 One-Handed Hemostasis Valves market, 2018 - 2030 (USD Million)
• Fig. 18 Others market, 2018 - 2030 (USD Million)
• Fig. 19 U.S. Hemostasis Valve market: Application outlook key takeaways
• Fig. 20 U.S. Hemostasis Valve market: Application movement analysis
• Fig. 21 Angiography market, 2018 - 2030 (USD Million)
• Fig. 22 Angioplasty market, 2018 - 2030 (USD Million)
• Fig. 23 U.S. Hemostasis Valve market: End Use outlook key takeaways
• Fig. 24 U.S. Hemostasis Valve market: End Use movement analysis
• Fig. 25 Hospitals market, 2018 - 2030 (USD Million)
• Fig. 26 Ambulatory surgical centers market, 2018 - 2030 (USD Million)
• Fig. 27 Others market, 2018 - 2030 (USD Million)
• Fig. 28 Strategy framework

U.S. Hemostasis Valve Market Size & Trends:

The U.S. hemostasis valve market size was estimated at USD 64.47 million in 2024 and is projected to grow at a CAGR of 5.4% from 2025 to 2033.The market is experiencing significant growth due to several key factors, including the rising incidence of cardiovascular diseases, favorable regulatory support, an aging population, and ongoing technological advancements. A notable driver is the increasing preference for minimally invasive procedures, which offer advantages such as less pain, shorter hospital stays, quicker recovery, and a reduced risk of complications compared to traditional open surgeries.

This shift is fueling the demand for medical devices that support these techniques. Hemostasis valves play a critical role in minimally invasive catheter-based procedures by ensuring controlled blood flow and preventing leakage during interventions.

Air pollution is increasingly recognized as a major contributor to the rise in cardiovascular diseases. Both chronic and short-term exposures significantly raise the risk of cardiovascular emergencies and mortality in the U.S. The World Heart Report 2024 highlights that air pollution worsens all major cardiovascular diseases (CVDs). In 2019, nearly 70% of the 4.2 million deaths linked to ambient air pollution were due to cardiovascular issues, particularly ischemic heart disease (1.9 million deaths) and stroke (900,000 deaths). As a result, there is an increased need for diagnostic and therapeutic procedures such as angiography and angioplasty, where hemostasis valves play a crucial role in maintaining patient safety by regulating blood flow during catheter-based interventions.

Technological advancements in medical devices are pivotal in driving the market growth. Ongoing technological advancements are playing a key role in improving the performance and reliability of hemostasis valves. Manufacturers are continuously innovating to enhance valve design, material quality, and compatibility with a variety of catheter sizes and interventional tools. These improvements help reduce the risk of blood leakage, improve ease of use for clinicians, and enhance patient safety during minimally invasive procedures. For example, Merit Medical Systems offers advanced hemostasis valves such as the Merit AccessPLUS and Honor Hemostasis Valves, which are designed with ergonomic features, superior sealing mechanisms, and robust hemostatic control. These innovations reflect the industry's focus on optimizing procedural efficiency and reducing complications in catheter-based interventions.

U.S. Hemostasis Valve Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. hemostasis valve market report based on type, application, and end use:

• Type Outlook (Revenue, USD Million, 2021 - 2033)
• Hemostasis Valve Y- Connectors
• Double Y- Y-Connector Hemostasis Valves
• One-Handed Hemostasis Valves
• Others
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Angiography
• Angioplasty
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Ambulatory Surgical Centers
• Others

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Type
  • 1.2.2. Application
  • 1.2.3. End Use
  • 1.2.4. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Volume price analysis (Model 1)
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type outlook
  • 2.2.2. Application outlook
  • 2.2.3. End Use outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Hemostasis Valve Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rising prevalence of coronary artery disease (CAD)
    • 3.2.1.2. Advancements in technologies
    • 3.2.1.3. Shift towards minimally invasive procedures
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Product recalls
    • 3.2.2.2. Clinical complexity and procedural risks
• 3.3. U.S. Hemostasis Valve Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. U.S. Hemostasis Valve Market: Type Estimates & Trend Analysis

• 4.1. U.S. Hemostasis Valve Market: Type Dashboard
• 4.2. U.S. Hemostasis Valve Market: Type Movement Analysis
• 4.3. U.S. Hemostasis Valve Market by Type, Revenue
• 4.4. Hemostasis Valve Y-Connectors
  • 4.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
• 4.5. Double Y-Connector Hemostasis Valves
  • 4.5.1. Market estimates and forecast 2021 to 2033 (USD Million)
• 4.6. One-Handed Hemostasis Valves
  • 4.6.1. Market estimates and forecast 2021 to 2033 (USD Million)
• 4.7. Others
  • 4.7.1. Market estimates and forecast 2021 to 2033 (USD Million)

Chapter 5. U.S. Hemostasis Valve Market: Application Estimates & Trend Analysis

• 5.1. U.S. Hemostasis Valve Market: Application Dashboard
• 5.2. U.S. Hemostasis Valve Market: Application Movement Analysis
• 5.3. U.S. Hemostasis Valve Market by Application, Revenue
• 5.4. Angiography
  • 5.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
• 5.5. Angioplasty
  • 5.5.1. Market estimates and forecast 2021to 2033 (USD Million)

Chapter 6. U.S. Hemostasis Valve Market: End Use Estimates & Trend Analysis

• 6.1. U.S. Hemostasis Valve Market: End Use Dashboard
• 6.2. U.S. Hemostasis Valve Market: End Use Movement Analysis
• 6.3. U.S. Hemostasis Valve Market by End Use, Revenue
• 6.4. Hospitals
  • 6.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
• 6.5. Ambulatory Surgical Centers
  • 6.5.1. Market estimates and forecast 2021 to 2033 (USD Million)
• 6.6. Others
  • 6.6.1. Market estimates and forecast 2021 to 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Manufacturers
• 7.2. Company/Competition Categorization
• 7.3. Vendor Landscape
  • 7.3.1. Key company market share analysis, 2024
• 7.4. Company Profiles
  • 7.4.1. Boston Scientific Corporation
    • 7.4.1.1. Company overview
    • 7.4.1.2. Financial performance
    • 7.4.1.3. Product benchmarking
    • 7.4.1.4. Strategic initiatives
  • 7.4.2. Teleflex Incorporated
    • 7.4.2.1. Company overview
    • 7.4.2.2. Financial performance
    • 7.4.2.3. Product benchmarking
    • 7.4.2.4. Strategic initiatives
  • 7.4.3. Merit Medical Systems
    • 7.4.3.1. Company overview
    • 7.4.3.2. Financial performance
    • 7.4.3.3. Product benchmarking
    • 7.4.3.4. Strategic initiatives
  • 7.4.4. B. Braun
    • 7.4.4.1. Company overview
    • 7.4.4.2. Financial performance
    • 7.4.4.3. Product benchmarking
    • 7.4.4.4. Strategic initiatives
  • 7.4.5. Terumo Corporation
    • 7.4.5.1. Company overview
    • 7.4.5.2. Financial performance
    • 7.4.5.3. Product benchmarking
    • 7.4.5.4. Strategic initiatives
  • 7.4.6. Abbott
    • 7.4.6.1. Company overview
    • 7.4.6.2. Financial performance
    • 7.4.6.3. Product benchmarking
    • 7.4.6.4. Strategic initiatives
  • 7.4.7. Argon Medical Devices
    • 7.4.7.1. Company overview
    • 7.4.7.2. Financial performance
    • 7.4.7.3. Product benchmarking
    • 7.4.7.4. Strategic initiatives
  • 7.4.8. Freudenberg Medical
    • 7.4.8.1. Company overview
    • 7.4.8.2. Financial performance
    • 7.4.8.3. Product benchmarking
    • 7.4.8.4. Strategic initiatives
  • 7.4.9. DeRoyal Industries, Inc.
    • 7.4.9.1. Company overview
    • 7.4.9.2. Financial performance
    • 7.4.9.3. Product benchmarking
    • 7.4.9.4. Strategic initiatives
  • 7.4.10. Antmed Corporation
    • 7.4.10.1. Company overview
    • 7.4.10.2. Financial performance
    • 7.4.10.3. Product benchmarking
    • 7.4.10.4. Strategic initiatives